Bristol-Myers Squibb, ConcertAI Sign Cancer Real World Data Pact
NewsMedia Coverage
Bristol-Myers Squibb plans to use ConcertAI’s Real-World Data and AI platform eurekaHealth to speed up the process “through novel health economic outcomes and clinical development synthetic control arm studies.”